Replimune to Present at the 42nd Annual J.P. Morgan Healthcare Conference

<p>WOBURN, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced that Philip Astley-Sparke, Chief Executive Officer of Replimune, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 11:15 […]</p>
<p>The post <a href="https://forextv.com/top-news/replimune-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conference/">Replimune to Present at the 42nd Annual J.P. Morgan Healthcare Conference</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>